| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/30/2012 | CN102475839A 肺癌防治口服液 Oral cancer prevention |
| 05/30/2012 | CN102475822A 宫颈癌防治口服液 Oral Cervical Cancer Prevention |
| 05/30/2012 | CN102475802A 防治肠癌口服液 Oral cancer prevention |
| 05/30/2012 | CN102475787A 保肝护肝多糖片 Hepatoprotective polysaccharide sheet |
| 05/30/2012 | CN102475786A 植物多糖片 Plant polysaccharides sheet |
| 05/30/2012 | CN102475776A 癌敌畏 Cancer DDVP |
| 05/30/2012 | CN102475752A 肝治灵 Liver rule Ling |
| 05/30/2012 | CN102475739A Radix Salviae Miltiorrhizae water extract and preparation method thereof |
| 05/30/2012 | CN102475735A 胰腺癌防治片 Pancreatic Cancer Prevention sheet |
| 05/30/2012 | CN102475714A 壳寡糖单一化合物在免疫增强药物中的应用 Oligochitosan single compounds in immune-enhancing drugs in |
| 05/30/2012 | CN102475710A 薯蓣皂苷元及其衍生物在制备肿瘤化疗增敏药物中的应用 Diosgenin and its derivatives in the preparation of chemotherapy drugs in sensitizing |
| 05/30/2012 | CN102475709A 壳五糖在制备抑制肿瘤血管生成药物中的应用 In the preparation of the pentasaccharide shell inhibiting tumor angiogenesis medicaments |
| 05/30/2012 | CN102475701A Application of pyrone compound |
| 05/30/2012 | CN102475698A 丹酚酸l在制备治疗肿瘤药物中的应用 Sal l in the manufacture of a medicament for the treatment of cancer |
| 05/30/2012 | CN102475687A Decitabine freeze-dry powder injection solution |
| 05/30/2012 | CN102475682A 小檗碱脂质体及其制备方法 Berberine liposomes and its preparation method |
| 05/30/2012 | CN102178901B Medicament for treating uterus cancer |
| 05/30/2012 | CN102166338B Alpinia katsumadai-ginger composite, preparation method thereof and use thereof for preparing toxicity-attenuating and effect-increasing medicine for radiotherapy and chemotherapy of cancer |
| 05/30/2012 | CN102145158B Ginger and clove composition, preparation method of ginger and clove composition and use of ginger and clove composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy |
| 05/30/2012 | CN102133298B Two-aqueous-phase method for extracting total saponin from bittersweet herb |
| 05/30/2012 | CN102114248B Poly (2-hydroxyl-3-(2-hydroxyethylamino) propyl methacrylate) (PGEA)-isoplyacid nano compound antitumor medicament and preparation method thereof |
| 05/30/2012 | CN102078560B Compound cantharis total extract preparation and preparation method thereof |
| 05/30/2012 | CN102078542B Traditional Chinese medicine combination for treating acute granulocyte AML-M4 leukemia |
| 05/30/2012 | CN102078530B Traditional Chinese medicine combination for treating acute granulocyte AML-M2 leukemia |
| 05/30/2012 | CN102078368B Chinese traditional medicine extract preparation for treating cancer and preparation method thereof |
| 05/30/2012 | CN102078345B Preparation method of actinidia arguta flavonoids |
| 05/30/2012 | CN102076346B Pharmaceutical compositions for human and preparation of bismuth or zinc agent |
| 05/30/2012 | CN102048987B Traditional Chinese medicine composition for treating acute myeloblastic leukemia (AML) M3 |
| 05/30/2012 | CN102038915B Traditional Chinese medicament for treating hysteromyoma and preparation method thereof |
| 05/30/2012 | CN102038652B Melphalan multi-targeted drug carrying system, and preparation method and application thereof |
| 05/30/2012 | CN102008438B Cis-platinum lung cancer-resistant active targeting concealed liposomes and preparation method thereof |
| 05/30/2012 | CN102008434B Compound docetaxel ester microsphere injection and preparation method thereof |
| 05/30/2012 | CN102002041B Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity |
| 05/30/2012 | CN102000208B Method for extracting and preparing medlar leaf flavone |
| 05/30/2012 | CN102000046B Application of antrodia camphorata cyclohexenone compound in preparing medicine for inhibiting growth of pancreatic cancer tumor cells |
| 05/30/2012 | CN101978975B Haematococcus extract preparation, and preparation method and use thereof |
| 05/30/2012 | CN101972246B Medicament for treating cancer, preparation method thereof and application thereof to preparation of medicaments |
| 05/30/2012 | CN101967142B Thiazoleamide compound and medical application thereof in treating malignant tumor |
| 05/30/2012 | CN101954052B Traditional Chinese medicine for treating cancers and preparation method thereof |
| 05/30/2012 | CN101953850B Preparation method and application of oyster shell extract |
| 05/30/2012 | CN101953847B Application of zinc hydroxide in preparation of anti-cancer drugs |
| 05/30/2012 | CN101953805B Method for preparing antitumor medical preparation |
| 05/30/2012 | CN101942445B Nucleic acid aptamer derivative and application thereof in preparation of medicament carrier |
| 05/30/2012 | CN101919841B Application of eudesmane-type sesquiterpenoids |
| 05/30/2012 | CN101909633B Use of a gamma-secretase inhibitor for treating cancer |
| 05/30/2012 | CN101879170B Anti-tumor application of malonyl astragaloside I and aglycon thereof |
| 05/30/2012 | CN101862324B Application of monascus color components and derivatives thereof in fighting cancers |
| 05/30/2012 | CN101856351B Composition and use thereof in preparation of RXR receptor transcription inhibitor |
| 05/30/2012 | CN101851250B Organotin hydroximic acid compound, preparation method thereof and application thereof |
| 05/30/2012 | CN101849972B Banding detection method of Cordyceps sinensis DNA fingerprint high resolution ratio |
| 05/30/2012 | CN101843584B Composite of all-trans-retinoic acid and liposome and application thereof |
| 05/30/2012 | CN101837065B Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof |
| 05/30/2012 | CN101829059B Magnetic lipid nano particle and preparation method |
| 05/30/2012 | CN101824406B Recombinant beta-lactamase-RGD-fusion protein and application thereof in medicine |
| 05/30/2012 | CN101824014B Compounds with anti-tumor activity in chloranthus japonicus and purpose thereof |
| 05/30/2012 | CN101785842B Pharmaceutical composition for leukemia treatment and preparation method thereof |
| 05/30/2012 | CN101756900B Elemene micro-emulsion |
| 05/30/2012 | CN101747384B 5-chlorine salicylyl hydrazine triphenyltin chloride coordination compound, as well as preparation method and application thereof |
| 05/30/2012 | CN101732551B Black lotus raw juice cancer preventing and treating medicament |
| 05/30/2012 | CN101653416B Tumor dual target liposome mediated by integrin and preparation method thereof |
| 05/30/2012 | CN101648973B Water-soluble taxane and preparation method thereof |
| 05/30/2012 | CN101627994B Novel anti-tumor application of organic small-molecular compound JFD-03554 |
| 05/30/2012 | CN101623359B Preparation method of drug composite with lung cancer resisting effect |
| 05/30/2012 | CN101611014B Acylaminopyrazoles as FGFR inhibitors |
| 05/30/2012 | CN101602768B Method for purifying sesamin and sesamolin |
| 05/30/2012 | CN101591646B Dendritic cell vaccine for treating human cervical carcinoma |
| 05/30/2012 | CN101591371B Method for preparing gemcitabine or analogues thereof through halogen-exchange fluorination |
| 05/30/2012 | CN101589025B Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 05/30/2012 | CN101583616B Aza-benzothiophenyl compounds and methods of use |
| 05/30/2012 | CN101583603B Aromatic 1,4-di-carboxylamides and their use |
| 05/30/2012 | CN101575379B Soluble VEGFR difunctional fusion receptors, preparation method and use thereof |
| 05/30/2012 | CN101573361B Novel aminopyrimidine derivative as plk1 inhibitor |
| 05/30/2012 | CN101573358B Pyrido (2, 3-D) pyrimidinone compounds and their use as PI3 inhibitors |
| 05/30/2012 | CN101570554B Method for preparing zinc supplementing agent carboxymethyl chitosan oligosaccharide zinc |
| 05/30/2012 | CN101565445B Method for preparing high-purity veratramine and jervine |
| 05/30/2012 | CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same |
| 05/30/2012 | CN101547935B Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2012 | CN101524465B External dipping medicine for remedying cancer |
| 05/30/2012 | CN101516366B Oxindole derivatives as anticancer agents |
| 05/30/2012 | CN101506204B Human protein tyrosine phosphatase inhibitors and methods of use |
| 05/30/2012 | CN101505777B Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia |
| 05/30/2012 | CN101492711B Uses of MAGEA9 gene |
| 05/30/2012 | CN101490076B 3'-ethynylcytidine derivative |
| 05/30/2012 | CN101433716B Composition for treating malignant solid tumors and preparation thereof and use |
| 05/30/2012 | CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides |
| 05/30/2012 | CN101402667B Glycosylation modified nitric oxide donor type oleaolic acid compounds, preparation and uses thereof |
| 05/30/2012 | CN101370789B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 05/30/2012 | CN101362679B Antrodia camphoratea pimelie kelone compound for inhibiting B type hepatitis virus |
| 05/30/2012 | CN101360748B Inhibitors of c-met and uses thereof |
| 05/30/2012 | CN101321527B Method of treating abnormal cell growth |
| 05/30/2012 | CN101306093B Decoction for treating esophagus cancer haematemesis |
| 05/30/2012 | CN101288475B Production method of flavor panax ginseng |
| 05/30/2012 | CN101273130B Nucleic acid agents for downregulating H19, and methods of using same |
| 05/30/2012 | CN101148667B Preparation and use for affinity human albumin nucleic acid aptamer |
| 05/30/2012 | CN101148666B Nucleic acid adapter with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof |
| 05/30/2012 | CN101130539B Indole-substituteing imidazoline-2-ketones derivant, preparing method and uses of the same |
| 05/30/2012 | CN101053403B Anti-senility anti-fatigue body-beautifying food and preparation method thereof |
| 05/30/2012 | CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 05/29/2012 | US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 05/29/2012 | US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |